Cost-Effectiveness Of Extracorporeal Cardiopulmonary Resuscitation In Patients With Refractory Cardiac Arrest

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F14%3A00221211" target="_blank" >RIV/68407700:21460/14:00221211 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.jval.2014.08.1435" target="_blank" >http://dx.doi.org/10.1016/j.jval.2014.08.1435</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jval.2014.08.1435" target="_blank" >10.1016/j.jval.2014.08.1435</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Cost-Effectiveness Of Extracorporeal Cardiopulmonary Resuscitation In Patients With Refractory Cardiac Arrest

Popis výsledku v původním jazyce

Objectives Extracorporeal life support (ECLS) has been recently introduced as a therapeutic option for refractory cardiac arrest (extracorporeal cardiopulmonary resuscitation - ECPR). Despite growing evidence demonstrating improved survival rate with ECPR in refractory cardiac arrest, a number of questions remains unanswered and data on cost-effectiveness of this approach are still insufficient. Methods Retrospective cost-effectiveness analysis was performed from the provider's perspective. Sixteen patients undergoing ECPR were included into the analysis (ECPR group) and the data were compared with 35 subjects with conventional CPR for refractory cardiac arrest (non-ECPR group). Results In the ECPR group seven out of sixteen patients were weaned from ECMO, four of them with good neurological outcomes (CPC 1); three patients survived one year with CPC 1, one patient survived one year with severe neurological dysfunction (CPC 3) and one patient with persisting coma (CPC 4). In comparison

Název v anglickém jazyce

Cost-Effectiveness Of Extracorporeal Cardiopulmonary Resuscitation In Patients With Refractory Cardiac Arrest

Popis výsledku anglicky

Objectives Extracorporeal life support (ECLS) has been recently introduced as a therapeutic option for refractory cardiac arrest (extracorporeal cardiopulmonary resuscitation - ECPR). Despite growing evidence demonstrating improved survival rate with ECPR in refractory cardiac arrest, a number of questions remains unanswered and data on cost-effectiveness of this approach are still insufficient. Methods Retrospective cost-effectiveness analysis was performed from the provider's perspective. Sixteen patients undergoing ECPR were included into the analysis (ECPR group) and the data were compared with 35 subjects with conventional CPR for refractory cardiac arrest (non-ECPR group). Results In the ECPR group seven out of sixteen patients were weaned from ECMO, four of them with good neurological outcomes (CPC 1); three patients survived one year with CPC 1, one patient survived one year with severe neurological dysfunction (CPC 3) and one patient with persisting coma (CPC 4). In comparison

Druh

O - Ostatní výsledky

CEP obor

FQ - Veřejné zdravotnictví, sociální lékařství

OECD FORD obor

—

Projekt

<a href="/cs/project/NT11532" target="_blank" >NT11532: Hodnocení zdravotnických prostředků</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů